RecruitingAML, ChildhoodAmlAcute Myeloid Leukemia, Pediatric
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This trial represents a single institution phase I/II pilot study with the primary objective of establishing the safety and feasibility of generating and infusing ML NK cells after TCRαβ haplo-HCT.
Sponsor: Washington University School of Medicine
Where it's recruiting
Missouri
St Louis
Source: ClinicalTrials.gov · NCT06158828 · last updated 2026-08-24